Skip to main content
Samuel Agresta, MD, Oncology, Lexington, MA

SamuelAgrestaMDMPH TM

Oncology Lexington, MA

Vice President, Agios Clinical Development

Dr. Agresta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Agresta's full profile

Already have an account?

Education & Training

  • University of South Florida Morsani College of Medicine
    University of South Florida Morsani College of MedicineFellowship, Hematology and Medical Oncology, 2003 - 2006
  • Tulane University School of Medicine
    Tulane University School of MedicineResidency, Internal Medicine, 1999 - 2003
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 1999

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2006 - 2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Infinity Pharmaceuticals Announces Transition of Samuel Agresta, M.D., from Chief Medical Officer to Board of Directors
    Infinity Pharmaceuticals Announces Transition of Samuel Agresta, M.D., from Chief Medical Officer to Board of DirectorsAugust 22nd, 2019
  • Therapeutics Expands Leadership Team with Two C-suite Appointments
    Therapeutics Expands Leadership Team with Two C-suite AppointmentsSeptember 16th, 2019
  • Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Ratings Summary as of Dec 18, 2018
    Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Ratings Summary as of Dec 18, 2018December 18th, 2018